AUD 0.01
(-14.29%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 60 Thousand AUD | 290.35% |
2023 | 15.37 Thousand AUD | -43.38% |
2022 | 27.14 Thousand AUD | -87.16% |
2021 | 211.48 Thousand AUD | 0.0% |
2020 | - AUD | 0.0% |
2019 | - AUD | 0.0% |
2018 | - AUD | 0.0% |
2017 | - AUD | -100.0% |
2016 | 63.96 Thousand AUD | -19.95% |
2015 | 79.9 Thousand AUD | -90.61% |
2014 | 850.85 Thousand AUD | -7.38% |
2013 | 918.65 Thousand AUD | -63.97% |
2012 | 2.54 Million AUD | 41.66% |
2011 | 1.79 Million AUD | -66.51% |
2010 | 5.37 Million AUD | 147.99% |
2009 | 2.16 Million AUD | 34.53% |
2008 | 1.61 Million AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 36 Thousand AUD | 0.0% |
2024 FY | 60 Thousand AUD | 290.35% |
2024 Q4 | 24 Thousand AUD | 0.0% |
2023 Q2 | 4271.00 AUD | 0.0% |
2023 Q4 | 11.1 Thousand AUD | 0.0% |
2023 FY | 15.37 Thousand AUD | -43.38% |
2022 Q2 | 13.57 Thousand AUD | 0.0% |
2022 Q4 | 13.57 Thousand AUD | 0.0% |
2022 FY | 27.14 Thousand AUD | -87.16% |
2021 Q2 | - AUD | 0.0% |
2021 FY | 211.48 Thousand AUD | 0.0% |
2021 Q4 | 211.48 Thousand AUD | 0.0% |
2020 Q4 | - AUD | 0.0% |
2020 Q2 | - AUD | 0.0% |
2020 FY | - AUD | 0.0% |
2019 Q2 | - AUD | 0.0% |
2019 Q4 | - AUD | 0.0% |
2019 FY | - AUD | 0.0% |
2018 FY | - AUD | 0.0% |
2018 Q2 | - AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2017 FY | - AUD | -100.0% |
2016 FY | 63.96 Thousand AUD | -19.95% |
2016 Q2 | - AUD | 0.0% |
2015 Q2 | 120.17 Thousand AUD | 0.0% |
2015 FY | 79.9 Thousand AUD | -90.61% |
2014 Q1 | 229.66 Thousand AUD | 0.0% |
2014 FY | 850.85 Thousand AUD | -7.38% |
2014 Q4 | -322.19 Thousand AUD | -251.47% |
2014 Q3 | 212.71 Thousand AUD | -52.38% |
2014 Q2 | 446.66 Thousand AUD | 94.49% |
2013 Q3 | 229.66 Thousand AUD | -58.65% |
2013 FY | 918.65 Thousand AUD | -63.97% |
2013 Q4 | 229.66 Thousand AUD | 0.0% |
2013 Q2 | 555.38 Thousand AUD | 24.78% |
2013 Q1 | 445.08 Thousand AUD | 0.0% |
2012 Q2 | 445.08 Thousand AUD | 64.68% |
2012 Q3 | 445.08 Thousand AUD | 0.0% |
2012 Q4 | 445.08 Thousand AUD | 0.0% |
2012 FY | 2.54 Million AUD | 41.66% |
2012 Q1 | 270.27 Thousand AUD | 0.0% |
2011 FY | 1.79 Million AUD | -66.51% |
2011 Q1 | 397.47 Thousand AUD | 0.0% |
2011 Q3 | 270.27 Thousand AUD | 0.0% |
2011 Q4 | 270.27 Thousand AUD | 0.0% |
2011 Q2 | 270.27 Thousand AUD | -32.0% |
2010 Q2 | 397.47 Thousand AUD | -2.2% |
2010 Q3 | 397.47 Thousand AUD | 0.0% |
2010 Q1 | 406.43 Thousand AUD | 0.0% |
2010 Q4 | 397.47 Thousand AUD | 0.0% |
2010 FY | 5.37 Million AUD | 147.99% |
2009 Q1 | 327.91 Thousand AUD | 0.0% |
2009 Q4 | 406.43 Thousand AUD | 0.0% |
2009 FY | 2.16 Million AUD | 34.53% |
2009 Q3 | 406.43 Thousand AUD | 0.0% |
2009 Q2 | 406.43 Thousand AUD | 23.94% |
2008 Q3 | 327.91 Thousand AUD | 0.0% |
2008 FY | 1.61 Million AUD | 0.0% |
2008 Q4 | 327.91 Thousand AUD | 0.0% |
2008 Q2 | 327.91 Thousand AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AdAlta Limited | 1.73 Million AUD | 96.547% |
Biome Australia Limited | 13 Million AUD | 99.539% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | 79.948% |
Biotron Limited | - AUD | -Infinity% |
Acrux Limited | 5.09 Million AUD | 98.821% |
Alterity Therapeutics Limited | 4.01 Million AUD | 98.507% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 90.03% |
BTC Health Limited | 16.36 Thousand AUD | -266.748% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 99.195% |
CSL Limited | 22.41 Billion AUD | 100.0% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.479% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.932% |
Immutep Limited | 3.5 Million AUD | 98.289% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.974% |
Noxopharm Limited | 2.4 Million AUD | 97.5% |
Prescient Therapeutics Limited | 3.71 Million AUD | 98.384% |
Race Oncology Limited | 4 Million AUD | 98.501% |
Starpharma Holdings Limited | 8.28 Million AUD | 99.276% |
Tissue Repair Ltd | 152.24 Thousand AUD | 60.589% |
EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.91% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | -227.511% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | 36.81% |
Patrys Limited | 1.39 Million AUD | 95.696% |
Orthocell Limited | 5.31 Million AUD | 98.871% |
Imugene Limited | - AUD | -Infinity% |
PYC Therapeutics Limited | 22.05 Million AUD | 99.728% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | 93.275% |
Cynata Therapeutics Limited | 2.31 Million AUD | 97.409% |
Arovella Therapeutics Limited | 17 Thousand AUD | -252.941% |
Nanollose Limited | 12.5 Thousand AUD | -379.962% |
Invex Therapeutics Ltd | 1.21 Million AUD | 95.051% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Amplia Therapeutics Limited | 4.45 Million AUD | 98.653% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 95.206% |
Nyrada Inc. | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.988% |
Dimerix Limited | 583.47 Thousand AUD | 89.717% |
PharmAust Limited | - AUD | -Infinity% |
Hexima Limited | - AUD | -Infinity% |
AnteoTech Limited | 460.39 Thousand AUD | 86.968% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 8.815% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | 87.33% |
Actinogen Medical Limited | 9.93 Million AUD | 99.396% |
Immuron Limited | 4.9 Million AUD | 98.776% |
Argenica Therapeutics Limited | 2.59 Million AUD | 97.69% |